Canada Spends Logo

Explore our Budget 2026 analysis

Contribution: Industrial Research Assistance Program – Contributions to Firms

Traferox Technologies Inc

$424,050.00

Development of new perfusion applications

FY 2023-24 · 2023-06-05

Summary
Traferox will design, manufacture, and validate systems that can perform normothermic ex vivo perfusion of the liver and the heart. In normothermic ex vivo organ perfusion, solid organs are perfused with a solution containing red blood cells and maintained at body temperature. Normothermic ex vivo organ perfusion enables detailed functional assessment of the organ and assessment of their suitability for transplant. This project will create systems suitable for preclinical research.
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Location
Mississauga|Mississauga, Ontario, Canada
Recipient Type
For-profit organization
Business Number
717995286
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions

Amendments

Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.

AmendmentDateFiscal YearTotal
02023-06-052023-24$272,500.00
12023-06-052023-24$380,050.00
32023-06-052023-24$424,050.00

As published

Additional Information
This agreement has been amended 2 time(s). The total amended value is 44,000 dollars.
Additional Information (French)
Cet accord a été modifié 2 fois La valeur totale des modifications est de 44 000 dollars.
Agreement End Date
2024-08-31
Agreement Number
1006748
Agreement Start Date
2023-06-05
Agreement Title
Development of new perfusion applications
Agreement Title (French)
Développement de nouvelles applications de perfusion
Agreement Type
Contribution
Agreement Value
$424,050.00
Amendment Date
2024-02-20
Amendment Number
3
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Traferox will design, manufacture, and validate systems that can perform normothermic ex vivo perfusion of the liver and the heart. In normothermic ex vivo organ perfusion, solid organs are perfused with a solution containing red blood cells and maintained at body temperature. Normothermic ex vivo organ perfusion enables detailed functional assessment of the organ and assessment of their suitability for transplant. This project will create systems suitable for preclinical research.
Description (French)
Traferox concevra, fabriquera et validera des systèmes capables de réaliser une perfusion ex vivo normothermique du foie et du cœur. Dans la perfusion normothermique ex vivo, les organes solides sont perfusés avec une solution contenant des globules rouges et maintenus à la température du corps. La perfusion ex vivo normothermique d’organes permet une évaluation fonctionnelle détaillée de l’organe et une évaluation de son aptitude à la transplantation. Ce projet permettra de créer des systèmes adaptés à la recherche préclinique.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Mississauga--Erin Mills
Federal Riding (French)
Mississauga--Erin Mills
Federal Riding Number
35060
NAICS Code
339110
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
717995286
Recipient City
Mississauga|Mississauga
Recipient Country
CA
Recipient Legal Name
Traferox Technologies Inc
Recipient Postal Code
L5L 5Y7
Recipient Province or Territory
ON
Recipient Type
F
Reference Number
172-2023-2024-Q1-1006748